目的  观察口服营养补充复配蛋白组件改善消化道恶性肿瘤患者营养状况的效果，为提高恶性肿瘤患者的综合治疗水平提供依据。方法  对106例消化道恶性肿瘤患者在饮食基础上应用复配蛋白组件，对其进行自身对照观察，收集口服营养补充复配蛋白组件前后的总蛋白、白蛋白、运铁蛋白、淋巴细胞、白细胞、中性粒细胞水平结果，对其进行统计学分析。结果  应用口服营养补充复配蛋白组件后，消化道恶性肿瘤患者的总蛋白[（56.59±8.74）g/L VS（63.55±7.03）g/L，t=-9.313，P＜0.05）]、白蛋白[（31.86±4.74）g/L VS（36.16±4.94）g/L，t=-9.919，P＜0.05）]、运铁蛋白[（0.15±0.05±4.74）g/L VS（0.21±0.11）g/L，t=-5.163，P＜0.05）]、淋巴细胞[（1.41±1.08）×109/L VS（1.99±2.95）×109/L ，t=-2.433，P＜0.05）]、白细胞[（8.36±3.85）×109/L VS（7.41±3.16）×109/L ，t=3.007，P＜0.05）]、中性粒细胞水平[（6.52±3.91）×109/L VS（5.41±3.08）×109/L，t=3.476，P＜0.05）]，各项指标均有改善，差异具有统计学意义。结论 口服营养补充复配蛋白组件能够改善消化道恶性肿瘤患者的营养状况。

Abstract:  ObjectiveTo observe the effect of oral nutritional supplementation with complex protein components on improving the nutritional status of patients with digestive tract malignant tumors, so as to provide a basis for improving the comprehensive treatment level of patients with malignant tumors. Methods106 patients with digestive tract malignant tumor in the diet on the basis of application of compound with protein components, self-reflection to observe, to collect oral nutritional supplements before and after the distribution of protein component of total protein, albumin, ferritin, lymphocytes, white blood cells, neutrophils level
for statistical analysis. ResultsUse of oral nutritional supplements after the distribution of protein components, the digestive tract malignant tumor patients with total protein [(56.59±8.74)g/L VS (63.55±7.03)g/L, t=-9.313, P<0.05], albumin[(31.86±4.74)g/LVS (36.16±4.94)g/L, t=-9.919, P<0.05)], ferritin[(0.15±0.05±4.74)g/L VS (0.21±0.11)g/L, t=-5.163, P<0.05)], lymphocyte [(1.41±1.08)×109/L VS (1.99±2.95)×109/L,  t=-2.433, P<0.05], leukocyte[(8.36±3.85)×109/L V(7.41±3.16)×109/L, t=3.007, P<0.05], neutrophil level [(6.52±3.91)×109/L VS (5.41±3.08)×109/L, t=3.476, P<0.05], all indicators improved, and the difference was statistically significant. ConclusionOral nutritional supplement complex protein components can improve the nutritional status and value of patients with digestivetract malignant tumors.